Youth Gender Medications Limited in England, Part of Big Shift in Europe
April 10, 2024

(New York Times) – England’s move is part of a broader shift in northern Europe, where health officials have been concerned by soaring demand for adolescent gender treatments in recent years. Many patients also have mental health conditions that make it difficult to pinpoint the root cause of their distress, known as dysphoria. (Read More)